NMR-determined lipoprotein subclass profile predicts type 2 diabetes

Diabetes Res Clin Pract. 2009 Jan;83(1):132-9. doi: 10.1016/j.diabres.2008.11.007. Epub 2008 Dec 16.


Aims: To determine whether nuclear magnetic resonance (NMR)-determined lipoprotein profiles predict type 2 diabetes.

Methods: Subjects were 813 male and female participants in the Melbourne Collaborative Cohort Study, aged 40-69 years at baseline (1990-1994), and with a baseline fasting plasma glucose <7.0 mmol/L. Incident type 2 diabetes was identified in 1994-1998 by self-report and confirmation from doctors. Eligible cases and a random group of controls were selected, with NMR data available for 59 cases and 754 non-cases.

Results: Concentration of very low density lipoprotein (VLDL) particles (positive) and high density lipoprotein (HDL) particle size (negative) were selected by stepwise regression as predictors of type 2 diabetes. These associations were independent of other non-lipid risk factors, but not plasma triglycerides. Factor analysis identified a factor from NMR variables, explaining 47% of their variation, and characterized by a positive correlation with VLDL, particularly large and medium sized; more low density lipoprotein (LDL) that were smaller; and relatively smaller, but not more HDL particles. This factor was positively associated with diabetes incidence, but not independently of triglycerides.

Conclusions: We identified an atherogenic NMR lipoprotein profile in people who developed diabetes, but this did not improve diabetes prediction beyond conventional triglyceride levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / metabolism*
  • Female
  • Humans
  • Lipoproteins / analysis*
  • Lipoproteins / classification*
  • Magnetic Resonance Spectroscopy* / methods
  • Male
  • Middle Aged


  • Lipoproteins